Suppr超能文献

先天性心脏病胎儿干预后的围产期结局及宫内并发症:观察性研究的系统评价和荟萃分析

Perinatal outcomes and intrauterine complications following fetal intervention for congenital heart disease: systematic review and meta-analysis of observational studies.

作者信息

Araujo Júnior E, Tonni G, Chung M, Ruano R, Martins W P

机构信息

Department of Obstetrics, Paulista School of Medicine - Federal University of São Paulo (EPM-UNIFESP), São Paulo, Brazil.

Department of Obstetrics and Gynecology, Prenatal Diagnostic Center, Guastalla Civil Hospital, AUSL Reggio Emilia, Italy.

出版信息

Ultrasound Obstet Gynecol. 2016 Oct;48(4):426-433. doi: 10.1002/uog.15867. Epub 2016 Sep 15.

Abstract

OBJECTIVE

To assess perinatal outcomes and intrauterine complications following fetal intervention for congenital heart disease (CHD).

METHODS

A systematic review and meta-analysis were performed following an electronic search of PubMed and Scopus databases (last searched August 2015). Perinatal outcomes that were assessed included fetal death, live birth, preterm delivery < 37 weeks' gestation and neonatal death. Intrauterine complications that were assessed included bradycardia requiring treatment and hemopericardium requiring drainage. Estimated proportions were reported as mean (95% CI). Inconsistency was assessed using the I statistic.

RESULTS

An electronic search identified 2279 records, of which 29 studies (11 retrospective cohort and 18 case reports) were considered eligible for analysis. Fetal death after treatment of CHD by aortic valvuloplasty was reported in three studies, with a rate of 31% (95% CI, 9-60%), after pulmonary valvuloplasty in one study, with a rate of 25% (95% CI, 10-49%), after septoplasty in one study, with a rate of 14% (95% CI, 6-28%) and after pericardiocentesis and/or pericardioamniotic shunt placement in 24 studies, with a rate of 29% (95% CI, 18-41%). Bradycardia requiring treatment was reported after aortic valvuloplasty in two studies, with a rate of 52% (95% CI, 16-87%), after pulmonary valvuloplasty in one study, with a rate of 44% (95% CI, 23-67%), and after septoplasty in one study, with a rate of 27% (95% CI, 15-43%).

CONCLUSIONS

Current evidence on the effectiveness of prenatal intervention for CHD derives mostly from case reports and a few larger series; no study was randomized. Although the results of the meta-analysis are encouraging in terms of perinatal survival, they should be interpreted with caution when comparing with procedures performed after delivery. Copyright © 2016 ISUOG. Published by John Wiley & Sons Ltd.

摘要

目的

评估先天性心脏病(CHD)胎儿干预后的围产期结局及宫内并发症。

方法

在对PubMed和Scopus数据库进行电子检索(最后检索时间为2015年8月)后,进行了系统评价和荟萃分析。评估的围产期结局包括胎儿死亡、活产、孕周<37周的早产和新生儿死亡。评估的宫内并发症包括需要治疗的心动过缓和需要引流的心包积血。估计比例报告为均值(95%CI)。使用I统计量评估异质性。

结果

电子检索共识别出2279条记录,其中29项研究(11项回顾性队列研究和18项病例报告)被认为符合分析条件。三项研究报告了经主动脉瓣成形术治疗CHD后的胎儿死亡情况,发生率为31%(95%CI,9%-60%);一项研究报告了经肺动脉瓣成形术治疗后的胎儿死亡情况,发生率为25%(95%CI,10%-49%);一项研究报告了经房间隔成形术后的胎儿死亡情况,发生率为14%(95%CI,6%-28%);24项研究报告了心包穿刺和/或心包羊膜分流术后的胎儿死亡情况,发生率为29%(95%CI,18%-41%)。两项研究报告了经主动脉瓣成形术后需要治疗的心动过缓情况,发生率为52%(95%CI,16%-87%);一项研究报告了经肺动脉瓣成形术后需要治疗的心动过缓情况,发生率为44%(95%CI,23%-67%);一项研究报告了经房间隔成形术后需要治疗的心动过缓情况,发生率为27%(95%CI,15%-43%)。

结论

目前关于产前干预治疗CHD有效性的证据主要来自病例报告和少数较大规模的系列研究;没有随机对照研究。尽管荟萃分析的结果在围产期生存方面令人鼓舞,但与产后进行的手术相比时应谨慎解读。版权所有©2016国际妇产科超声学会。由约翰·威利父子有限公司出版。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验